Wei, Mengchao-知名学者引用-被知名学者引用-36人次-全球学者库

知名学者引用

除了所发表论文的被引用频次、期刊质量能够彰显学者的学术影响力以外，被知名学者引用也是一项学术评价的重要指标。
当前全球学者库认定的知名学者包括：诺贝尔奖、菲尔兹奖、图灵奖等奖项获得者，多个国家的院士，全球学者库“2023全球学者学术影响力排行版”入榜的前10万学者等。

Wei, Mengchao 中山大学被知名学者引用：36人次（黄金会员以上可以申请导出本人论文被全部知名学者引用的数据）

1. Robert S. Langer 美国 M.I.T, USA 1989美国医学院院士;1992美国科学院院士;2013沃尔夫化学奖 Biodegradable ring-shaped implantable device for intravesical therapy of bladder disorders

2. 刘允怡中国香港中文大学中国科学院院士 Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcin..

3. 郑树森中国浙江大学中国工程院院士 Virtual navigation-guided radiofrequency ablation for recurrent hepatocellular carcinoma invisible o..

4. Fabio,Farinati 意大利 University of PADUA Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelin..

5. Fabio,Piscaglia 意大利 University of Bologna Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelin..

6. Trevisani, Franco 意大利 University of Bologna Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelin..

7. Atlas, Steven J. 美国 Harvard University Cost-Effectiveness of Nadofaragene Firadenovec and Pembrolizumab in Bacillus Calmette-Guerin Immunot..

8. Steven D,Pearson 美国 Institute Clinic & Economy Review Cost-Effectiveness of Nadofaragene Firadenovec and Pembrolizumab in Bacillus Calmette-Guerin Immunot..

9. Itaru,Endo 日本 Yokohama City University Tumor Burden Score and Serum Alpha-fetoprotein Subclassify Intermediate-Stage Hepatocellular Carcino..

10. 沈锋中国海军军医大学 Tumor Burden Score and Serum Alpha-fetoprotein Subclassify Intermediate-Stage Hepatocellular Carcino..

11. Timothy M,Pawlik 美国 OHIO STATE University Tumor Burden Score and Serum Alpha-fetoprotein Subclassify Intermediate-Stage Hepatocellular Carcino..

12. Aurelien,Marabelle 法国 UNIVERSITE PARIS SACLAY Synergizing liver systemic treatments with interventional oncology: friend or foe?

13. Thierry,De Baere 法国 Institute GUSTAVE ROUSSY Synergizing liver systemic treatments with interventional oncology: friend or foe?

14. Giovanni,Traverso 美国 Massachusetts Institute of Technology, MIT Biodegradable ring-shaped implantable device for intravesical therapy of bladder disorders

15. 陈敏山中国中山大学 Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcin..

16. 郑传胜中国华中科技大学 Tumor feeding artery contraction and metastasis inhibition after transarterial chemoembolization com..

17. 郑传胜中国华中科技大学 Comparison of the Efficacy Among Transcatheter Arterial Chemoembolization (TACE)-Radiofrequency Abla..

18. 陈罡中国广西医科大学 Decreased expression of transcription factor Homeobox A11 and its potential target genes in bladder ..

19. Gilaad G,Kaplan 加拿大 University of Calgary Trends and Projections in National United States Health Care Spending for Gastrointestinal Malignanc..

20. Siddharth,Singh 美国 University of California San Diego Trends and Projections in National United States Health Care Spending for Gastrointestinal Malignanc..